Magnesium is the most common divalent metal cation present in mammalian cells. It is estimated that the average 150 pound adult stores approximately 24 grams of magnesium in body tissues. Magnesium is an intracellular ion with relatively high cytosolic concentration in the millimolar range. Up to 99% of total body stores of this mineral reside either in bone (54%) or intracellularly (inside of the cell – 45%) – wherein skeletal muscles and soft tissue harbor most of the intracellular component (2). The magnesium inside the cells is mostly bound to cellular molecules and machinery that include proteins, enzymes, phospholipids, and deoxyribonucleic acid (DNA), as well as energy molecules including adenosine triphosphate (ATP). In this way magnesium is set to activate the metabolic enzymes and cellular machinery in the different cell compartments, as well as promote ATP production and activation – ATP can only be optimally functional when bound to magnesium.
Magnesium Deficiency and Testing
The National Health and Nutrition Examination Survey (NHANES) surveyed Americans’ intake of magnesium between 2005-2006. The conclusion was that almost 50% of Americans have insufficient intakes of magnesium from food and water. This means that millions of Americans do not consume the Recommended Daily Allowance (RDA) of magnesium (310-420 mg – depending on age and gender). It is important to note that these minimal numbers are required in order to avoid overt signs of disease and they do not imply optimal levels needed.
It is difficult to accurately measure magnesium levels as currently there is no one cost-effective and easily-available test that can reliably predict magnesium stores. Serum or plasma magnesium levels do not accurately predict total magnesium tissue status. This is because plasma levels of magnesium account to about 1% of total magnesium. Plasma levels are balanced with magnesium from bone and tissues. What this means is that the body stores can become substantially depleted, yet the plasma levels being tightly regulated may not move in terms of magnesium concentration giving the wrong idea that the person is not deficient. Overall, plasma should be thought of as the body’s “highway” transportation system and in some cases, will not reveal deficiencies hidden within tissues.
At the moment, the best test for predicting magnesium deficiency, in terms of cost effectiveness and accuracy, would be the red blood cell (RBC) magnesium. This test can be ordered through your physician or via online services which will provide you a diagnostic laboratory requisition so that you can get drawn and tested. The RBC magnesium test is much more accurate than serum/plasma magnesium levels in predicting magnesium stores. This is because it has a larger test dynamic range and the numbers given by this test tend to move up or down based on how much magnesium a person may be ingesting or if the body stores are low. Many providers use this test to monitor therapeutic dosing of patients.
Magnesium and Immunity
Magnesium is not typically viewed in context of immunity. As important as it is in ameliorating symptoms of chronic syndromes that include insomnia, anxiety or fibromyalgia – it is actually an important immunomodulatory factor. The following discussion herein will focus on magnesium in context of immunity. The role of magnesium in controlling the arms of the immune system has been known since at least the 1990’s. These include cells of the innate immune system, such as macrophages, as well as cells of the adaptive immune response including T lymphocytes.
The two arms of immunity work together in a complex and coordinated fashion in order to monitor, detect, and initiate responses against foreign invaders. The innate response is the first line of defense and is genetically pre-programmed to detect variety of common patterns or chemicals present in viruses, bacteria, and parasites. The adaptive immune response, in turn, is “specialized” and is able to modify its genes in innumerable combinations in order to create extremely specific agents, such as antibodies, that will find and lock on invading pathogens. The adaptive immune response is dependent on the innate system for reporting invading pathogens. In contrast, the innate immune response will typically undergo the first battle but then will depend on adaptive immunity to secure long term protection from that same invader.
X-linked Immunodeficiency with Magnesium Defect, EBV infection and Neoplasia (XMEN)
One of the most prominent demonstrations regarding the role of magnesium in immunity occurred with the discovery of the XMEN syndrome in 2011. The group, led by Dr. Michael Lenardo from National Institute of Health (NIH), demonstrated detection of a magnesium transporter defect that results in CD4+ T cell lymphopenia (i.e. low number of specific T cells). The defective protein, called MAGT1, is present on the X chromosomes (hence XMEN). This makes it more likely that males will present with symptoms as females have two X chromosomes and can compensate with the second normal copy of the MAGT1 gene.
MAGT1 is a magnesium selective transporter which is present in immune cells – in this case it would be T cells, which are part of adaptive immunity. As discussed briefly above, adaptive immune cells have the ability to re-arrange a portion of their DNA in order to create cell receptors that can identify numerous pathogens. Once T cells encounter their cognate pathogen they will be activated.
Activation of T cells occurs when the T Cell Receptor (TCR) is activated during infections. Optimal TCR activation requires highly coordinated interactions of numerous and diverse array of enzymes that are activated in a web of signaling interactions. Some of those proteins that are activated allow release of magnesium inside of the cells. What Dr. Lenardo and his group found is that without functional magnesium transport, enzymes that subsequently allow calcium in the cell are not properly activated. This in turn causes major defect in T cell activation and interlukin-2 (IL-2) production (3, 4). IL-2 is a critical cytokine that T cells produce in order to increase survival and multiplication of pathogen-specific T cells. The importance of IL-2 can be observed in the pharmaceutical world where IL-2 mechanisms are directly targeted to promote immunosuppression in individuals undergoing organ transplantation.
MAGT1 deficiency here clearly demonstrates the effects of not enough magnesium inside of immune cells. Magnesium is so important that its deficiency (i.e. MAGT1 dysfunction), in some ways, will clinically resemble AIDS patients that have very low CD4+ T cells due to HIV-mediated destruction – that is, susceptibility to variety of infections.
Magnesium Corrects Defects in Interlukin-2-inducible T Cell Kinase Deficiency (ITK)
A recent study demonstrated another fascinating display of correcting magnesium-related immunodeficiency. In this case, a patient presented with another genetic defect (ITK deficiency) that has similar clinical symptoms to MAGT1 deficiency discussed above. Here, the authors administered magnesium to the patient’s cells in-vitro (i.e. in cell culture) and found that magnesium restored the function of cytotoxic CD8+ T cells. This observation, combined with MAGT1 correction in-vivo (patients supplemented orally) demonstrated the importance of this mineral to the function of immune cells.
Epstein Barr Virus and Innate Immunity
Epstein Barr Virus (EBV) is member of the human Herpes virus family that includes Cytomegalovirus (CMV) and Human Herpes-virus 6 (HHV6). These viruses are associated with immune dysregulation, and Chronic Fatigue Syndrome (CFS) – also termed Myalgic Encephalomyelitis (ME). Loss of a magnesium transporter MAGT1 in immune cells, not surprisingly, coincides with increased levels of EBV in blood. High chronic levels of EBV predispose one to lymphoma. Part of the reason behind unchecked levels of EBV in MAGT1 deficient patients is the dysfunction of another arm of the immune system, Natural Killer (NK) innate immune cells. As the name implies, these “natural” killer cells are programmed to find infected cells (as well as cancer cells), lock on them, and then literally fire cell-killing material at them causing their obliteration. However, in the case of MAGT1 deficiency these NK cells become non-responsive and unable to mediate clearance of EBV. Importantly, magnesium supplementation in these patients corrects the impairment in NK cells and allows clearance of EBV-infected cells. From these studies we can speculate that chronically low magnesium levels are likely to promote a spectrum of immunodeficiency similar to the gene dysfunction seen with MAGT1 protein.
NK cells are involved in clearance of numerous viruses, including respiratory viruses. In fact, Sorrento Therapeutics is studying NK cell based therapy for treatment of Coronavirus 2019-nCoV (COVID-19). Dr. Robert Hariri, CEO of Cellularity (partner of Sorrento Therapeutics) in a recent interview states
“Not everybody exposed to COVID-19 gets sick. That suggests that there is something fundamental about them that makes those who get sick and those who don’t get sick different – and we know that’s their immune systems.”
This is paramount, as one of the known modulators of immunity, specifically with NK cells, is magnesium. In essence, to have optimally functioning NK cells for overcoming viruses a person must have sufficient amounts of this mineral.
Therapeutic Dosing of Magnesium
In order to replenish already low magnesium levels one must undergo dosing (under medical guidance) for at least 1 month and then re-evaluate levels. As mentioned, magnesium RBC is currently the most cost effective with acceptable accuracy. In a study performed by Jigsaw Health, magnesium RBC levels were significantly increased by 30% within 90 days of oral supplementation. This coincided with substantial improvement of magnesium-related symptomology – i.e. symptom decrease of 63%.
There are several options of magnesium compounds, some of quality and others more or less useless in context of mineral repletion. In short, some of the best forms of magnesium compounds are the chelated molecules. This includes magnesium glycinate and magnesium malate. Additionally, magnesium chloride (known as “oil”) is an effective remedy for local application but can also be used internally.
There are several resources on which the reader can further entertain this subject. The list includes, Dr. Carolyn Dean (author of The Magnesium Miracle), Morley Robbins (author of the Root Cause Protocol), Dr. Mark Sircus (author of Transdermal Magnesium Therapy), and Thomas DeLauer (Fitness Expert). These sources delve into other physiological effects of magnesium not mentioned on this discussion which is centralized on magnesium-related immune responses.
Magnesium is an essential mineral and is required for numerous enzymatic reactions. ATP-utilizing enzymes require magnesium as a cofactor. Without this, the cellular machinery and metabolic functions will be substantially reduced. Magnesium levels can be increased in the cells and tissues with chelated or liquid forms that are generally safe to administer.
Immunodeficiency stems from several factors, including environmental and genetic factors. We now know that deficiency in a magnesium transporter protein, MAGT1, found on the cells’ plasma membrane results in immunodeficiency termed XMEN. This deficiency results in AIDS-like syndrome with lymphopenia and CD4+ T cell deficiency. Additionally, this deficiency creates defects in NK cells, which predisposes the carrier to multiple viral infections as well as increased risk of cancer. The latter is due to reduced tumor-surveillance mediated in part by NK cells.
Repletion of magnesium in genetically compromised individuals allows for correction of some of the presented defects. We can deduct from these findings that persons with low magnesium stores, but not genetically compromised, will have a higher chance of being in a spectrum of immunodeficiency, with chronic depletion probably causing overt symptoms. However, more studies need to specifically define what level of magnesium deficiency will correlate with immunodeficiency observed in XMEN syndrome.
We Need Your Help
More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.
This article was published originally on March 23, 2020.